BridgeMD
New treatment option for Dysmenorrhea Primary
Official title Comparison of Different Physiotherapy Techniques in Dysmenorrhea
ClinicalTrials.gov ID: NCT07022106
What this study is testing
- What it's testing
- This study is investigating the effects of myofascial release technique \& kinesiotape in managing dysmenorrhea
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30, women only
You may be able to join if
- Diagnosis of primary dysmenorrhea,
- Moderate-to-severe pain during menstrual days 1-3,
- Regular menstrual cycles for past 6 months
You likely can't join if
- Secondary gynaecological conditions,
- Current use of pain medications,
- History of pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Beykoz, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Beykoz, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.